Logos Global Management

Logos Global Management, LP (also known as Logos Capital) is a San Francisco–based investment firm specializing in life sciences and biotechnology. As of March 2024, it managed approximately $1.5 billion in assets across eight pooled investment vehicles, with a strong focus on both private and public biotech companies

Dr. Arsani William, MD, MBA

Managing Partner / Chief Investment Officer

Dr. William serves as Managing Partner and Chief Investment Officer of Logos Capital, a global life science investment fund focused on private/public therapeutic innovation.

Prior to founding Logos, Dr. William was an investment professional at Farallon Capital Management, where he grew Farallon’s biopharma portfolio.

Dr. William holds an MD from Harvard Medical School, where he was a Gerald S. Foster Scholar, an MBA from Stanford’s Graduate School of Business, and a BS with Honors in Biology from Stanford University.

Dr. William currently serves on the board of Design Therapeutics (NASDAQ: DSGN) and is a board observer on Odyssey Therapeutics.

Nil

Companies with fund stakes involved in activist actions such as 13D filing(s) or proxy campaign(s).